Netherlands Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to

Publication Date	November 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	81
ISBN Number	not applicable
Product Code	GMD07667

Price

£1,960.00
approximately: $2,997 | €2,186

PDF

Order above formats by FAX

Summary

Netherlands Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to

Summary

This report is an essential source for indepth information and data relating to the Netherlands diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key subsegments of the diabetes care devices in Netherlands

Scope

The report provides diabetes care devices information broken down into detailed categories and segments in Netherlands.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the diabetes care devices market in Netherlands.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
- 3.1 Diabetes Care Devices
- 3.2 Glucose Monitoring
  - 3.2.1 Blood Glucose Meter
  - 3.2.2 Blood Glucose Strips
- 3.3 Insulin Delivery
  - 3.3.1 Insulin Pen
  - 3.3.2 Insulin Pump
  - 3.3.3 Insulin Syringes
4 Healthcare Sector Review
- 4.1 Healthcare Expenditure
- 4.2 Healthcare Infrastructure
- 4.3 Healthcare Policy
  - 4.3.1 Health Insurance Act
  - 4.3.2 Healthcare Allowance Act
  - 4.3.3 The Exceptional Medical Expenses Act
5 Regulation System
- 5.1 Medical Equipment Approval Process
  - 5.1.1 Classification of Medical Devices
  - 5.1.2 Conformity Assessment Process
    - 5.1.2.1 Class I devices
    - 5.1.2.2 Class IIa devices
    - 5.1.2.3 Class IIb devices
    - 5.1.2.4 Class III devices
- 5.2 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
- 6.1 Pricing and Reimbursement in Netherlands
7 Distribution Structure
- 7.1 Distribution Structure in Netherlands
8 Diabetes Care Devices In Netherlands
- 8.1 Diabetes Care Devices Cross Country Comparison (20002012)
- 8.2 Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), 20002012
- 8.3 Diabetes Care Devices, Netherlands, Category Volume (Units), 20002012
- 8.4 Diabetes Care Devices, Netherlands Company share (20062007)
9 Glucose Monitoring In Netherlands
- 9.1 Glucose Monitoring Overall Revenue (20002012)
- 9.2 Glucose Monitoring Overall Volume (20002012)
- 9.3 Glucose Monitoring Average Price (20002012)
- 9.4 Glucose Monitoring Distribution Share (20062007)
- 9.5 Glucose Monitoring, Netherlands, Company Share (20062007)
10 Insulin Delivery In Netherlands
- 10.1 Insulin Delivery Overall Revenue (20002012)
- 10.2 Insulin Delivery Overall Volume (20002012)
- 10.3 Insulin Delivery Average Price (20002012)
- 10.4 Insulin Delivery Distribution Share (20062007)
- 10.5 Insulin Delivery, Netherlands, Company Share (20062007)
11 F. HoffmannLa Roche Ltd. Company Profile
- 11.1 Company Overview
- 11.2 Value Chain Analysis
  - 11.2.1 Manufacturing
    - 11.2.1.1 In House Manufacturing
    - 11.2.1.2 Outsourcing
  - 11.2.2 Product Development
    - 11.2.2.1 Regulatory Approvals
    - 11.2.2.2 Clinical Trials
    - 11.2.2.3 Research and Development
  - 11.2.3 Sales and Marketing
    - 11.2.3.1 Partnerships and Alliances
    - 11.2.3.2 Licensing Agreements
12 LifeScan, Inc. Company Profile
- 12.1 Company Overview
  - 12.1.1 LifeScan, Inc. Pipeline Products by Equipment Type
  - 12.1.2 LifeScan, Inc. Pipeline Products by Development Stage
  - 12.1.3 LifeScan, Inc. Pipeline Products By Therapy Area
  - 12.1.4 LifeScan, Inc. Pipeline Products By Clinical Trials
  - 12.1.5 LifeScan, Inc. Pipeline Products By News Summary
13 Bayer HealthCare AG Company Profile
- 13.1 Company Overview
- 13.2 Value Chain Analysis
  - 13.2.1 Manufacturing
    - 13.2.1.1 In House Manufacturing
    - 13.2.1.2 Outsourcing
  - 13.2.2 Product Development
    - 13.2.2.1 Regulatory Approvals
    - 13.2.2.2 Clinical Trials
    - 13.2.2.3 Research and Development
  - 13.2.3 Sales and Marketing
    - 13.2.3.1 Partnerships and Alliances
    - 13.2.3.2 Licensing Agreements
- 13.3 Bayer HealthCare AG Pipeline Products
  - 13.3.1 Bayer HealthCare AG Pipeline Products by Equipment Type
  - 13.3.2 Bayer HealthCare AG Pipeline Products by Development Stage
  - 13.3.3 Bayer HealthCare AG Pipeline Products by Therapy Area
  - 13.3.4 Bayer HealthCare AG Pipeline Products by News Summary
14 Novo Nordisk A/S Company Profile
- 14.1 Company Overview
  - 14.1.1 Novo Nordisk A/S Pipeline Products By Equipment Type
  - 14.1.2 Novo Nordisk A/S Pipeline Products By Development Stage
  - 14.1.3 Novo Nordisk A/S Pipeline Products by Therapy Area
  - 14.1.4 Novo Nordisk A/S Pipeline Products by Clinical Trials
15 Abbott Laboratories Company Profile
- 15.1 Company Overview
- 15.2 Value Chain Analysis
  - 15.2.1 Manufacturing
    - 15.2.1.1 In House Manufacturing
  - 15.2.2 Product Development
    - 15.2.2.1 Regulatory Approvals
    - 15.2.2.2 Research and Development
    - 15.2.2.3 Clinical Trials
  - 15.2.3 Sales and Marketing
    - 15.2.3.1 Partnerships and Alliances
  - 15.2.4 Abbott Laboratories Pipeline Products By Equipment Type
  - 15.2.5 Abbott Laboratories Pipeline Products By Development Stage
  - 15.2.6 Abbott Laboratories Pipeline Products by Therapy Area
  - 15.2.7 Abbott Laboratories Pipeline Products by Clinical Trials
  - 15.2.8 Abbott Laboratories Pipeline Products by News Summary
16 Eli Lilly and Company Company Profile
- 16.1 Company Overview
- 16.2 Value Chain Analysis
  - 16.2.1 Manufacturing
    - 16.2.1.1 In House Manufacturing
    - 16.2.1.2 Outsourcing
  - 16.2.2 Product Development
    - 16.2.2.1 Regulatory Approvals
    - 16.2.2.2 Clinical Trials
    - 16.2.2.3 Research and Development
  - 16.2.3 Sales and Marketing
    - 16.2.3.1 Partnerships and Alliances
    - 16.2.3.2 Licensing Agreements
    - 16.2.3.3 Edistribution
  - 16.2.4 Eli Lilly and Company Pipeline Products By Equipment Type
  - 16.2.5 Eli Lilly and Company Pipeline Products by Development Stage
  - 16.2.6 Eli Lilly and Company Pipeline Products By Therapy Area
17 Diabetes Management International BV Company Profile
- 17.1 Company Overview
- 18.1 Global Markets Direct Research Methodology
- 18.2 Coverage
- 18.3 Secondary Research
- 18.4 Primary Research
- 18.5 Models
- 18.6 Forecasts
- 18.7 Expert Panels
- 18.8 Currency Conversion
- 18.9 Contact Us
- 18.10 Disclaimer
1.1 List of Tables
- Table 1: Doctors by Specialty in Netherlands, 20002006
- Table 2: Hospital Wards by Type in Netherlands, 20002006
- Table 3: Diabetes Care Devices Cross Country Comparison (20002012)
- Table 4: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), 20002012
- Table 5: Diabetes Care Devices, Egypt, Portfolio Analysis, 20002012
- Table 6: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), Historic, 20002007
- Table 7: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), Forecast, 20072012
- Table 8: Diabetes Care Devices, Netherlands, Category Volume (Units), 20002012
- Table 9: Diabetes Care Devices, Netherlands, Category Volume (Units), Historic, 20002007
- Table 10: Diabetes Care Devices, Netherlands, Category Volume (Units), Forecast, 20072012
- Table 11: Diabetes Care Devices, Netherlands Company share by Revenue ($ mn), 20062007
- Table 12: Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment , Historic, 20002007
- Table 13: Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment , Forecast, 20072012
- Table 14: Glucose Monitoring, Netherlands, Overall Volume (Units), Historic, 20002007
- Table 15: Glucose Monitoring, Netherlands, Overall Volume (Units), Forecast, 20072012
- Table 16: Glucose Monitoring, Netherlands, Average Price ($), Historic, 20002007
- Table 17: Glucose Monitoring, Netherlands, Average Price ($), Forecast,, 20072012
- Table 18: Glucose Monitoring, Netherlands, Distribution Share by Revenue ($mn), 20062007
- Table 19: Glucose Monitoring, Netherlands, Company Share by Revenue ($ mn), 20062007
- Table 20: Insulin Delivery, Netherlands, Revenue ($ mn) by Segment , Historic, 20002007
- Table 21: Insulin Delivery, Netherlands, Revenue ($ mn) by Segment , Forecast, 20072012
- Table 22: Insulin Delivery, Netherlands, Overall Volume (Units), Historic, 20002007
- Table 23: Insulin Delivery, Netherlands, Overall Volume (Units), Forecast, 20072012
- Table 24: Insulin Delivery, Netherlands, Average Price ($), Historic, 20002007
- Table 25: Insulin Delivery, Netherlands, Average Price ($), Forecast,, 20072012
- Table 26: Insulin Delivery, Netherlands, Distribution Share by Revenue ($mn), 20062007
- Table 27: Insulin Delivery, Netherlands, Company Share by Revenue ($ mn), 20062007
- Table 28: LifeScan, Inc. Pipeline Products by Equipment Type
- Table 29: LifeScan, Inc. Pipeline Products by Development Stage
- Table 30: LifeScan, Inc. Pipeline Products By Therapy Area
- Table 31: LifeScan, Inc. Pipeline Products By Clinical Trials
- Table 32: LifeScan, Inc. Pipeline Products By News Summaries
- Table 33: Bayer HealthCare AG Pipeline Products by Equipment Type
- Table 34: Bayer HealthCare AG Pipeline Products By Development Stage
- Table 35: Bayer HealthCare AG Pipeline Products By Therapy Area
- Table 36: Bayer HealthCare AG Pipeline Products By News Summaries
- Table 37: Novo Nordisk A/S Pipeline Products by Equipment Type
- Table 38: Novo Nordisk A/S Pipeline Products By Development Stage
- Table 39: Novo Nordisk A/S Pipeline Products By Therapy Area
- Table 40: Novo Nordisk A/S Pipeline Products By Clinical Trials
- Table 41: Abbott Laboratories Pipeline Products by Equipment Type
- Table 42: Abbott Laboratories Pipeline Products By Development Stage
- Table 43: Abbott Laboratories Pipeline Products By Therapy Area
- Table 44: Abbott Laboratories Pipeline Products By Clinical Trials
- Table 45: Abbott Laboratories Pipeline Products By News Summaries
- Table 46: Eli Lilly and Company Pipeline Products by Equipment Type
- Table 43: Eli Lilly and Company Pipeline Products by Development Stage
- Table 47: Eli Lilly and Company Pipeline Products By Therapy Area
- Table 48: Currency Conversion from USD to Local Currency at 2007 Constant Rate
1.2 List of Figures
- Figure 1: Total Healthcare Expenditure in Netherlands, 2000 2006
- Figure 2: Healthcare Financing Framework in Netherlands, 2005
- Figure 3: Flowchart for Classification of Noninvasive Devices in Netherlands, 2007
- Figure 4: Flowchart for Classification of Invasive Devices in Netherlands, 2007
- Figure 5: Flowchart for Classification of Invasive Devices in Netherlands, 2007
- Figure 6: Flowchart for Classification of Invasive Devices in Netherlands, 2007
- Figure 7: Flowchart for Classification of Invasive Devices in Netherlands, 2007
- Figure 8: Flowchart for Classification of Active Devices in Netherlands, 2007
- Figure 9: Flowchart for Classification of Active Devices in Netherlands, 2007
- Figure 10: Flowchart for Classification of Devices except Noninvasive, Invasive and Active Devices in Netherlands, 2007
- Figure 11: Conformity Assessment of ClassI Medical Devices in Netherlands, 2007
- Figure 12: Conformity Assessment of ClassIIa Medical Devices in Netherlands, 2007
- Figure 13: Conformity Assessment of ClassIIb Medical Devices in Netherlands, 2007
- Figure 14: Conformity Assessment of ClassIII Medical Devices in Netherlands, 2007
- Figure 15: Diabetes Care Devices Cross Country Comparison (20002012)
- Figure 16: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), 20002012
- Figure 17: Diabetes Care Devices, Egypt, Portfolio Analysis, 20002012
- Figure 18: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), Historic, 20002007
- Figure 19: Diabetes Care Devices, Netherlands, Overall Revenues ($ mn), Forecast, 20072012
- Figure 20: Diabetes Care Devices, Netherlands, Category Volume (Units), 20002012
- Figure 21: Diabetes Care Devices, Netherlands, Category Volume (Units), Historic, 20002007
- Figure 22: Diabetes Care Devices, Netherlands, Category Volume (Units), Forecast, 20072012
- Figure 23: Diabetes Care Devices, Netherlands Company share (%), 2007
- Figure 24: Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment , Historic, 20002007
- Figure 25: Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment , Forecast, 20072012
- Figure 26: Glucose Monitoring, Netherlands, Overall Volume (Units), Historic, 20002007
- Figure 27: Glucose Monitoring, Netherlands, Overall Volume (Units), Forecast, 20072012
- Figure 28: Glucose Monitoring, Netherlands, Company Share (%), 2007
- Figure 29: Insulin Delivery, Netherlands, Revenue ($ mn) by Segment , Historic, 20002007
- Figure 30: Insulin Delivery, Netherlands, Revenue ($ mn) by Segment , Forecast, 20072012
- Figure 31: Insulin Delivery, Netherlands, Company Share (%), 2007
- Figure 32: F. HoffmannLa Roche Ltd Value Chain Analysis
- Figure 33: Bayer HealthCare AG Value Chain Analysis
- Figure 34: Abbott Laboratories Value Chain Analysis
- Figure 35: Eli Lilly and Company Value Chain Analysis
- Figure 36: Global Markets Direct Methodology